GSK admits old Voltaren label was misleading
Competition & Consumer Protection February 19, 2018 8:43 pm By Christine Caulfield | Melbourne

Drug giants GlaxoSmithKline and Novartis have conceded part of the ACCC’s case that packaging on their Voltaren Osteo Gel breached the Australian Consumer Law, but […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.